APO Research
Talk to an analyst

APO RESEARCH · REPORT

Azacitidine for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Azacitidine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchAzacitidine for Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Azacitidine for Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Azacitidine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azacitidine for Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Azacitidine for Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Azacitidine for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azacitidine for Injection include Chia Tai Tianqing Pharmaceutical, TEVA, Jiangsu Hansoh Pharmaceutical, Sichuan Huiyu Pharmaceutical, Viatris, Shilpa Medicare, Natco Pharma, Meitheal Pharmaceuticals and Lupin Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Azacitidine for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azacitidine for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azacitidine for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azacitidine for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Azacitidine for Injection Segment by Company

Chia Tai Tianqing Pharmaceutical

TEVA

Jiangsu Hansoh Pharmaceutical

Sichuan Huiyu Pharmaceutical

Viatris

Shilpa Medicare

Natco Pharma

Meitheal Pharmaceuticals

Lupin Limited

Dr. Reddy's Laboratories

Cipla

Celgene

Amneal Pharmaceuticals

Accord Healthcare

Azacitidine for Injection Segment by Type

Original Drug

Generic Drug

Azacitidine for Injection Segment by Application

Hospitals

Clinics

Others

Azacitidine for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azacitidine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azacitidine for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azacitidine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Azacitidine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Azacitidine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Azacitidine for Injection Industry Trends Table 2. Azacitidine for Injection Industry Drivers Table 3. Azacitidine for Injection Industry Opportunities and Challenges Table 4. Azacitidine for Injection Industry Restraints Table 5. Global Azacitidine for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Azacitidine for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Azacitidine for Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Azacitidine for Injection Sales Market Share by Manufacturers Table 9. Global Azacitidine for Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Azacitidine for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Azacitidine for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Azacitidine for Injection Manufacturers, Product Type & Application Table 13. Global Azacitidine for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Azacitidine for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Azacitidine for Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 20. Global Azacitidine for Injection Sales by Type (2027-2032) & (k units) Table 21. Global Azacitidine for Injection Sales Market Share by Type (2021-2026) Table 22. Global Azacitidine for Injection Sales Market Share by Type (2027-2032) Table 23. Global Azacitidine for Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Azacitidine for Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Azacitidine for Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Azacitidine for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Azacitidine for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global Azacitidine for Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 33. Global Azacitidine for Injection Sales by Application (2027-2032) & (k units) Table 34. Global Azacitidine for Injection Sales Market Share by Application (2021-2026) Table 35. Global Azacitidine for Injection Sales Market Share by Application (2027-2032) Table 36. Global Azacitidine for Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Azacitidine for Injection Revenue by Application (2021-2026) & (k units) Table 38. Global Azacitidine for Injection Revenue by Application (2027-2032) & (k units) Table 39. Global Azacitidine for Injection Revenue Market Share by Application (2021-2026) Table 40. Global Azacitidine for Injection Revenue Market Share by Application (2027-2032) Table 41. Global Azacitidine for Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Azacitidine for Injection Sales by Region (2021-2026) & (k units) Table 43. Global Azacitidine for Injection Sales Market Share by Region (2021-2026) Table 44. Global Azacitidine for Injection Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Azacitidine for Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 48. North America Azacitidine for Injection Sales by Country (2027-2032) & (k units) Table 49. Europe Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 51. Europe Azacitidine for Injection Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Azacitidine for Injection Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Azacitidine for Injection Sales by Country (2027-2032) & (k units) Table 58. Global Azacitidine for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Azacitidine for Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Azacitidine for Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Azacitidine for Injection Revenue Market Share by Region (2021-2026) Table 62. Global Azacitidine for Injection Revenue Market Share by Region (2027-2032) Table 63. Chia Tai Tianqing Pharmaceutical Company Information Table 64. Chia Tai Tianqing Pharmaceutical Business Overview Table 65. Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product Portfolio Table 67. Chia Tai Tianqing Pharmaceutical Recent Development Table 68. TEVA Company Information Table 69. TEVA Business Overview Table 70. TEVA Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. TEVA Azacitidine for Injection Product Portfolio Table 72. TEVA Recent Development Table 73. Jiangsu Hansoh Pharmaceutical Company Information Table 74. Jiangsu Hansoh Pharmaceutical Business Overview Table 75. Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product Portfolio Table 77. Jiangsu Hansoh Pharmaceutical Recent Development Table 78. Sichuan Huiyu Pharmaceutical Company Information Table 79. Sichuan Huiyu Pharmaceutical Business Overview Table 80. Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product Portfolio Table 82. Sichuan Huiyu Pharmaceutical Recent Development Table 83. Viatris Company Information Table 84. Viatris Business Overview Table 85. Viatris Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Viatris Azacitidine for Injection Product Portfolio Table 87. Viatris Recent Development Table 88. Shilpa Medicare Company Information Table 89. Shilpa Medicare Business Overview Table 90. Shilpa Medicare Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shilpa Medicare Azacitidine for Injection Product Portfolio Table 92. Shilpa Medicare Recent Development Table 93. Natco Pharma Company Information Table 94. Natco Pharma Business Overview Table 95. Natco Pharma Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Natco Pharma Azacitidine for Injection Product Portfolio Table 97. Natco Pharma Recent Development Table 98. Meitheal Pharmaceuticals Company Information Table 99. Meitheal Pharmaceuticals Business Overview Table 100. Meitheal Pharmaceuticals Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Meitheal Pharmaceuticals Azacitidine for Injection Product Portfolio Table 102. Meitheal Pharmaceuticals Recent Development Table 103. Lupin Limited Company Information Table 104. Lupin Limited Business Overview Table 105. Lupin Limited Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lupin Limited Azacitidine for Injection Product Portfolio Table 107. Lupin Limited Recent Development Table 108. Dr. Reddy's Laboratories Company Information Table 109. Dr. Reddy's Laboratories Business Overview Table 110. Dr. Reddy's Laboratories Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Dr. Reddy's Laboratories Azacitidine for Injection Product Portfolio Table 112. Dr. Reddy's Laboratories Recent Development Table 113. Cipla Company Information Table 114. Cipla Business Overview Table 115. Cipla Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Cipla Azacitidine for Injection Product Portfolio Table 117. Cipla Recent Development Table 118. Celgene Company Information Table 119. Celgene Business Overview Table 120. Celgene Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Celgene Azacitidine for Injection Product Portfolio Table 122. Celgene Recent Development Table 123. Amneal Pharmaceuticals Company Information Table 124. Amneal Pharmaceuticals Business Overview Table 125. Amneal Pharmaceuticals Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Amneal Pharmaceuticals Azacitidine for Injection Product Portfolio Table 127. Amneal Pharmaceuticals Recent Development Table 128. Accord Healthcare Company Information Table 129. Accord Healthcare Business Overview Table 130. Accord Healthcare Azacitidine for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Accord Healthcare Azacitidine for Injection Product Portfolio Table 132. Accord Healthcare Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Azacitidine for Injection Distributors List Table 136. Azacitidine for Injection Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Azacitidine for Injection Product Image Figure 2. Global Azacitidine for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azacitidine for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Azacitidine for Injection Sales (2021-2032) & (k units) Figure 5. Global Azacitidine for Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Azacitidine for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Azacitidine for Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Azacitidine for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Azacitidine for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Azacitidine for Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Azacitidine for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Azacitidine for Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Azacitidine for Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Azacitidine for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Azacitidine for Injection Sales Market Share by Application (2021-2032) Figure 22. Global Azacitidine for Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Azacitidine for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Azacitidine for Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Azacitidine for Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Azacitidine for Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Azacitidine for Injection Sales Market Share by Country (2021-2032) Figure 39. China Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Azacitidine for Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Azacitidine for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Azacitidine for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Azacitidine for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Azacitidine for Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Azacitidine for Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Azacitidine for Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Azacitidine for Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Azacitidine for Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Azacitidine for Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • TEVA
  • Jiangsu Hansoh Pharmaceutical
  • Sichuan Huiyu Pharmaceutical
  • Viatris
  • Shilpa Medicare
  • Natco Pharma
  • Meitheal Pharmaceuticals
  • Lupin Limited
  • Dr. Reddy's Laboratories
  • Cipla
  • Celgene
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Azacitidine for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Azacitidine for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Azacitidine for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Azacitidine for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Azacitidine for Injection Market Dynamics
  1. 2.1 Azacitidine for Injection Industry Trends
  2. 2.2 Azacitidine for Injection Industry Drivers
  3. 2.3 Azacitidine for Injection Industry Opportunities and Challenges
  4. 2.4 Azacitidine for Injection Industry Restraints
3 Azacitidine for Injection Market by Manufacturers
  1. 3.1 Global Azacitidine for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Azacitidine for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Azacitidine for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Azacitidine for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azacitidine for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Azacitidine for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Azacitidine for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azacitidine for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azacitidine for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azacitidine for Injection Tier 1, Tier 2, and Tier 3
4 Azacitidine for Injection Market by Type
  1. 4.1 Azacitidine for Injection Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Azacitidine for Injection Sales by Type
  5. 4.2.1 Global Azacitidine for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Azacitidine for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Azacitidine for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Azacitidine for Injection Revenue by Type
  9. 4.3.1 Global Azacitidine for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Azacitidine for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Azacitidine for Injection Revenue Market Share by Type (2021-2032)
5 Azacitidine for Injection Market by Application
  1. 5.1 Azacitidine for Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Azacitidine for Injection Sales by Application
  6. 5.2.1 Global Azacitidine for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Azacitidine for Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Azacitidine for Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Azacitidine for Injection Revenue by Application
  10. 5.3.1 Global Azacitidine for Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Azacitidine for Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Azacitidine for Injection Revenue Market Share by Application (2021-2032)
6 Global Azacitidine for Injection Sales by Region
  1. 6.1 Global Azacitidine for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azacitidine for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Azacitidine for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Azacitidine for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Azacitidine for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Azacitidine for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Azacitidine for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Azacitidine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Azacitidine for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Azacitidine for Injection Revenue by Region
  1. 7.1 Global Azacitidine for Injection Revenue by Region
  2. 7.1.1 Global Azacitidine for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Azacitidine for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Azacitidine for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Azacitidine for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Azacitidine for Injection Revenue (2021-2032)
  8. 7.2.2 North America Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Azacitidine for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Azacitidine for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Azacitidine for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Azacitidine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 8.2 TEVA
  8. 8.2.1 TEVA Company Information
  9. 8.2.2 TEVA Business Overview
  10. 8.2.3 TEVA Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TEVA Azacitidine for Injection Product Portfolio
  12. 8.2.5 TEVA Recent Developments
  13. 8.3 Jiangsu Hansoh Pharmaceutical
  14. 8.3.1 Jiangsu Hansoh Pharmaceutical Company Information
  15. 8.3.2 Jiangsu Hansoh Pharmaceutical Business Overview
  16. 8.3.3 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product Portfolio
  18. 8.3.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  19. 8.4 Sichuan Huiyu Pharmaceutical
  20. 8.4.1 Sichuan Huiyu Pharmaceutical Company Information
  21. 8.4.2 Sichuan Huiyu Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product Portfolio
  24. 8.4.5 Sichuan Huiyu Pharmaceutical Recent Developments
  25. 8.5 Viatris
  26. 8.5.1 Viatris Company Information
  27. 8.5.2 Viatris Business Overview
  28. 8.5.3 Viatris Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Viatris Azacitidine for Injection Product Portfolio
  30. 8.5.5 Viatris Recent Developments
  31. 8.6 Shilpa Medicare
  32. 8.6.1 Shilpa Medicare Company Information
  33. 8.6.2 Shilpa Medicare Business Overview
  34. 8.6.3 Shilpa Medicare Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shilpa Medicare Azacitidine for Injection Product Portfolio
  36. 8.6.5 Shilpa Medicare Recent Developments
  37. 8.7 Natco Pharma
  38. 8.7.1 Natco Pharma Company Information
  39. 8.7.2 Natco Pharma Business Overview
  40. 8.7.3 Natco Pharma Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Natco Pharma Azacitidine for Injection Product Portfolio
  42. 8.7.5 Natco Pharma Recent Developments
  43. 8.8 Meitheal Pharmaceuticals
  44. 8.8.1 Meitheal Pharmaceuticals Company Information
  45. 8.8.2 Meitheal Pharmaceuticals Business Overview
  46. 8.8.3 Meitheal Pharmaceuticals Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Meitheal Pharmaceuticals Azacitidine for Injection Product Portfolio
  48. 8.8.5 Meitheal Pharmaceuticals Recent Developments
  49. 8.9 Lupin Limited
  50. 8.9.1 Lupin Limited Company Information
  51. 8.9.2 Lupin Limited Business Overview
  52. 8.9.3 Lupin Limited Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Limited Azacitidine for Injection Product Portfolio
  54. 8.9.5 Lupin Limited Recent Developments
  55. 8.10 Dr. Reddy's Laboratories
  56. 8.10.1 Dr. Reddy's Laboratories Company Information
  57. 8.10.2 Dr. Reddy's Laboratories Business Overview
  58. 8.10.3 Dr. Reddy's Laboratories Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddy's Laboratories Azacitidine for Injection Product Portfolio
  60. 8.10.5 Dr. Reddy's Laboratories Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Azacitidine for Injection Product Portfolio
  66. 8.11.5 Cipla Recent Developments
  67. 8.12 Celgene
  68. 8.12.1 Celgene Company Information
  69. 8.12.2 Celgene Business Overview
  70. 8.12.3 Celgene Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Celgene Azacitidine for Injection Product Portfolio
  72. 8.12.5 Celgene Recent Developments
  73. 8.13 Amneal Pharmaceuticals
  74. 8.13.1 Amneal Pharmaceuticals Company Information
  75. 8.13.2 Amneal Pharmaceuticals Business Overview
  76. 8.13.3 Amneal Pharmaceuticals Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Amneal Pharmaceuticals Azacitidine for Injection Product Portfolio
  78. 8.13.5 Amneal Pharmaceuticals Recent Developments
  79. 8.14 Accord Healthcare
  80. 8.14.1 Accord Healthcare Company Information
  81. 8.14.2 Accord Healthcare Business Overview
  82. 8.14.3 Accord Healthcare Azacitidine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Accord Healthcare Azacitidine for Injection Product Portfolio
  84. 8.14.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azacitidine for Injection Value Chain Analysis
  2. 9.1.1 Azacitidine for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azacitidine for Injection Production Mode & Process
  6. 9.2 Azacitidine for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azacitidine for Injection Distributors
  9. 9.2.3 Azacitidine for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst